TriVascular Technologies (Santa Rosa, California), a company pursuing technologies to treat aortic abdominal aneurysms (AAA) raised $78 million in its Wall Street debut Wednesday on the Nasdaq Global Select Market. The company launched its initial public offering of 6.5 million shares of common stock priced at $12 a share, below the previously expected range of $13 to $15. Read More
